Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1150-1151
JournalNeurology
Volume70
Issue number13 Pt 2
DOIs
Publication statusPublished - 2008

Cite this